The FDA announced on Oct. 6, 2025, that Tandem Diabetes Care, Inc. is voluntarily recalling the Tandem Mobi insulin pump due to a software issue causing false vibration motor failure and potential hyperglycemia. Owners should contact the company for a remedy.
How to tell if you have it
- Brand: Tandem
- Product: Tandem Mobi Insulin Pump
- Catalog Numbers: 1010750, 1012719, 1013501, 1013655, 1013656, 1013700, 1014081
- Software Versions: 7.6.0.1, 7.6.0.3, 7.7.0.1
- Units Affected: 17,745
The hazard
The pump's vibration motor may fail due to a software issue, triggering Malfunction 12 which stops insulin delivery and data transmission to the mobile app. This malfunction could result in hyperglycemia.
Context
GovInfoNow's records show Tandem Diabetes Care, Inc. has 10 other recalls on record since April 23, 2018. Other recent recalls of similar products include the Tandem t:slim mobile application (July 16, 2026), Tandem pumps with Czech guide errors (Jan. 30, 2026), and Tandem t:slim X2 and Mobi insulin pumps with G7 sensor risk hypoglycemia (Aug. 5, 2025). Other recent recalls of similar products include the Medtronic MiniMed 780G Insulin Pump Recall (July 13, 2026), the Medtronic MiniMed 630G Insulin Pump Recall (Feb. 13, 2026), and the Medtronic MiniMed 640G Insulin Pump Recall (July 13, 2026).